Animal rights groups are voicing strong disapproval of a new initiative by Anduril, a defense technology firm, that seeks to create genetically modified military dogs. This endeavor raises ethical questions about the genetic alteration of animals.
The criticism is sparked by the launch of Warhound, a startup backed by Anduril founder Palmer Luckey and biotech entrepreneur Ben Lamm. The initiative has a hefty $200 million budget aimed at cloning and genetically modifying dogs for high-risk military missions, as reported by Fortune. Anduril is set to provide body armor, advanced sensors, and other technologies for use in the field.
“Warhound is outdated from the start, making it a cruel waste of resources and lives,” remarked Fleur Dawes, who manages communications at In Defense of Animals. She referenced past advancements, like Boston Dynamics’ robot dog, which showcased impressive capabilities back in 2018. Just recently, a Massachusetts State Police bomb squad used a robot to confront a dangerous situation, demonstrating the potential of robotic alternatives.
Stacy Lopresti-Goodman, director at the Animal Legal Defense Fund, expressed her concerns over the decision to genetically engineer dogs for warfare, deeming it a severe violation of the bond that humans have developed with dogs over thousands of years. She emphasized the potential harm that such modifications could bring.
PETA’s Senior Vice President, Colleen O’Brien, criticized the idea, stating that genetically altering dogs for military use is an outdated approach, especially as many organizations transition to robotics and AI technologies that can mitigate risks to dogs.
One online post echoed a sentiment that using dogs instead of robots could simply be a cost-saving measure for Anduril. This aligns with trends, as robot dogs are emerging as feasible replacements for their biological counterparts.
At a recent U.S. Army convention, officials discussed the capabilities of advanced robot dogs, noting their multifunctional designs and extensive application potential. These robots can carry substantial weights and can be outfitted for various military operations, minimizing ethical dilemmas associated with using live animals.
Luckey defended the project, suggesting that protective gear and genetic modifications would address health issues commonly seen in military dogs. However, some experts warn that the proposed genetic changes could lead to serious psychological repercussions for the animals.
According to Goodman, enhancements aimed at increasing a dog’s alertness could inadvertently lead to problems like anxiety or stress. Other experts emphasized that dogs should not be treated as mere tools, pointing out that genetic modifications could result in chronic health issues.
Warhound plans to begin by cloning high-performance Belgian Malinois and German Shepherds, targeting genes linked to various inherited conditions. They also aim to increase these dogs’ physical capabilities, tackling challenges such as explosive detection in more hazardous environments.
However, ethical dilemmas remain, particularly concerning dogs that do not meet enhanced performance criteria. Research indicates that many military dogs are discharged for behavioral issues, raising questions about their fates afterward.
The initiative not only seeks to create genetically altered dogs but also aims to solve a persistent supply issue, as the majority of U.S. military dogs are sourced from overseas. Currently, many of these dogs fail to qualify for service after an intensive selection process.
Support from the American Humane Society includes oversight of Warhound’s training programs and assistance in rehoming retired military dogs, echoing a commitment to their welfare.
Concerns also extend to the techniques used in the genetic modification process. Questions linger about the fate of puppies that don’t meet the set standards and the ethical implications of invasive reproductive practices.
Warhound anticipates delivering its first genetically engineered puppies by early 2027, with plans for them to be operational by 2028. Yet, the company has not finalized contracts with government agencies or determined prices for these modified dogs.
Dawes spelt out her view on the initiative, contesting that simply adding advanced tech to genetically altered dogs won’t ensure their safety. She argues it reduces these living beings to mere hardware, cautioning against the substantial financial investment in a program that appears to be treading into territory already explored by robots.
